BruttomessoDCostaSBaritussioA.Continuous subcutaneous insulin infusion (CSII) 30 years later: Still the best option for insulin therapy. Diabetes Metab Res Rev.2009;25 (2): 99–111.
3.
RubinRRPeyrotMChenXFriasJP, Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus. Diabetes Technol Ther.2010;12 (11): 901–6.
4.
MatziouVTsoumakasKVlahiotiEChrysicopoulouLGalanisPPetsiosKPerdikarisP.Factors influencing the quality of life of young patients with diabetes. J Diabetes.2011;3 (1): 82–90.
5.
Muller-GodeffroyETreichelSWagnerVM; German Working Group for Paediatric Pump Therapy. Investigation of quality of life and family burden issues during insulin pump therapy in children with type 1 diabetes mellitus—a large-scale multicentre pilot study. Diabet Med.2009;26 (5): 493–501.
6.
NuboerRBorsboomGJZoethoutJAKootHMBruiningJ.Effects of insulin pump vs. injection treatment on quality of life and impact of disease in children with type 1 diabetes mellitus in a randomized, prospective comparison. Pediatr Diabetes.2008;9 (4 Pt 1): 291–6.
7.
DoyleEAWeinzimerSASteffenATAhernJAVincentMTamborlaneWV, A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care.2004;27 (7): 1554–8.
8.
BruttomessoDCrazzolaraDMaranACostaSDal PosMGirelliALeporeGAragonaMIoriEValentiniUDel PratoSTiengoABuhrATrevisanRBaritussioA.In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med.2008;25 (3): 326–32.
9.
CohenDWeintrobNBenzaquenHGalatzerAFaymanGPhillipM.Continuous subcutaneous insulin infusion versus multiple daily injections in adolescents with type I diabetes mellitus: A randomized open crossover trial. J Pediatr Endocrinol Metab.2003;16 (7): 1047–50.
10.
DeVriesJHSnoekFJKostensePJMasurelNHeineRJ; Dutch Insulin Pump Study Group. A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabetes Care.2002;25 (11): 2074–80.
11.
MaahsDMHortonLAChaseHP, The use of insulin pumps in youth with type 1 diabetes. Diabetes Technol Ther.2010;12Suppl 1: S59–65.
12.
PickupJCSuttonAJ, Severe hypoglycaemia and glycaemic control in type 1 diabetes: Meta-analysis of multiple daily insulin injections compared with continuous subcutaneous insulin infusion. Diabet Med.2008;25 (7): 765–74.
13.
WiebeDJCroomAFortenberryKTButnerJButlerJSwinyardMTLindsayRDonaldsonDFosterCMurrayMBergCA, Parental involvement buffers associations between pump duration and metabolic control among adolescents with type 1 diabetes. J Pediatr Psychol.2010;35 (10): 1152–60.
14.
MissoMLEgbertsKJPageMO'ConnorDShawJ.Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev.2010; (1): CD005103.
15.
FuldKConradBBuckinghamBWilsonDM, Insulin pumps in young children. Diabetes Technol Ther.2010;12Suppl 1: S67–71.
16.
Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. Psychol Med.1998;28 (3): 551–8.
17.
SulmontVLassmann-VagueVGuerciBHanaireHLeblancHLeuteneggerEMihaileanuMTubiana-RufiN. Access of children and adolescents with type 1 diabetes to insulin pump therapy has greatly increased in France since 2001. Diabetes Metab.2011;37 (1): 59–63.
18.
Kosoko-LasakiSCookCTO'BrienRL, editors. Cultural Proficiency in Addressing Health Disparities. Sudbury, MA: Jones and Bartlett Learning; 2009.
19.
PickupJC, Are insulin pumps underutilized in type 1 diabetes? Yes. Diabetes Care.2006;29 (6): 1449–52.
